Golden
Serenity Bioworks

Serenity Bioworks

Serenity Bioworks is an immune-compatible gene therapy company founded in 2017 by Cody Shirriff.

Serenity is developing an immunomodulatory platform called CargoTek. Their initial focus is to improve AAV gene therapy for monogenic diseases like hemophilia A, inherited retinal diseases and neurodegenerative diseases.

Funding

In June 2018, Serenity Bioworks closed their Seed round. The amount raised was not disclosed. The round was led by SOSV.



Timeline

People

Name
Role
LinkedIn

Cody Shirriff

Founder



Spencer Berg

Founder



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References